Schering, Merck defend cholesterol drugs in ads
33756
Schering-Plough Corp and Merck & Co are defending their shared cholesterol treatments, Vytorin and Zetia, in advertisements after a failed study generated negative publicity.
708000
LONDON, Dec. 17 â As regulators wage war on unhealthy diets, cholesterol in food is increasingly unpopular. But it may have found a new role in advertising.
733605
U.S. health officials said on Friday they would review whether to take regulatory action over Merck & Co Inc  and Schering-Plough's  cholesterol medicine Vytorin following the drug's failure to work better than a generic drug in a study of plaque build-up in neck arteries.
153437
Dr. Robert Jarvikâs appearance in television ads for Lipitor has helped rekindle a smoldering debate.
575614
Merck and Schering report bad news, but how much will it affect sales?
280845
Merck &amp; Co.&#39;s campaign to defend itself in the wake of the recall of the pain reliever Vioxx intensified as it placed a package of three full-page ads in seven prominent newspapers beginning last Friday.
46530
A newspaper advertisement for AstraZeneca Plc&#39;s cholesterol drug Crestor that touts patient safety is misleading and should no longer be published, regulators warned in a letter released on Wednesday.
732137
U.S. health officials said on Friday they would review whether to take regulatory action over Merck & Co Inc and Schering-Plough's cholesterol medicine Vytorin following the drug's failure to work better than a generic drug in a study of plaque build-up in neck arteries.
323348
GlaxoSmithKline Plc fired another salvo in defense of diabetes treatment Avandia on Tuesday by taking out full-page advertisements in at least a dozen major U.S. newspapers in an attempt to reassure patients of the safety of the widely used medicine.
587839
Giving consumers access to cholesterol-lowering drugs without a prescription could expand use of the medicines and help fight the U.S. heart disease epidemic, drugmaker Merck & Co. Inc. told an advisory panel on Thursday.
759985
The government is questioning if too many of the wrong people will take cholesterol-lowering Mevacor if it's sold without a prescription, days before Merck & Co. makes its third try to move the drug over the counter.
87010
New data are due out on a promising cholesterol drug. But there are doubters.
61895
Dr. Robert Jarvikâs appearance in television ads for Lipitor has helped rekindle a smoldering debate over aiming ads for prescription drugs directly at consumers.
29618
Taking a drug that boosts &quot;good&quot; cholesterol and a separate pill that lowers &quot;bad&quot; cholesterol appears to be a more effective weapon against heart disease than taking a single drug, researchers say.
83518
Merck & Co and Schering-Plough Corp said a closely watched study involving its Vytorin cholesterol treatment failed to reach its main goal.
574773
A newspaper advertisement for AstraZeneca Plc's cholesterol drug Crestor that touts patient safety is misleading and should no longer be published, regulators warned in a letter released Wednesday.
235507
Merck next month will make its second try for approval to sell cholesterol drug Mevacor without a prescription. If the Food and Drug Administration approves, cholesterol drugs would